These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8295172)

  • 41. Eosinophilia-myalgia syndrome and fasciitis with an active alveolitis.
    Chauhan D; Mengel CE
    Kans Med; 1993 Jun; 94(6):175-7. PubMed ID: 8355447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Central nervous system inflammation in the eosinophilia-myalgia syndrome.
    Pixley JS; Eaton JM; Zweig RM
    Br J Rheumatol; 1993 Feb; 32(2):174. PubMed ID: 8428238
    [No Abstract]   [Full Text] [Related]  

  • 43. Serum cytokines and the eosinophilia myalgia syndrome.
    Clauw DJ; Zackrison LH; Katz P
    Ann Intern Med; 1992 Aug; 117(4):344-5. PubMed ID: 1463513
    [No Abstract]   [Full Text] [Related]  

  • 44. Use of cyclosporin A in the eosinophilia myalgia syndrome.
    Clauw DJ; Alloway JA; Katz P
    Ann Rheum Dis; 1993 Jan; 52(1):81-2. PubMed ID: 8427523
    [No Abstract]   [Full Text] [Related]  

  • 45. Interleukin-4 levels in the eosinophilia-myalgia syndrome.
    Kaufman LD; Gruber BL; Needleman BW
    Am J Med; 1991 Dec; 91(6):664-5. PubMed ID: 1750440
    [No Abstract]   [Full Text] [Related]  

  • 46. Eosinophilia-Myalgia Syndrome: Review and Reappraisal of Clinical, Epidemiologic and Animal Studies Symposium. Washington, D.C., USA, December 7-8, 1994. Proceedings.
    J Rheumatol Suppl; 1996 Oct; 46():1-110. PubMed ID: 9053528
    [No Abstract]   [Full Text] [Related]  

  • 47. Acute encephalopathy associated with the eosinophilia-myalgia syndrome.
    Adair JC; Rose JW; Digre KB; Balbierz JM
    Neurology; 1992 Feb; 42(2):461-2. PubMed ID: 1736188
    [No Abstract]   [Full Text] [Related]  

  • 48. Eosinophilia-myalgia syndrome: how well prepared is Australian public health?
    Smith W; Leeder SR
    Med J Aust; 1993 Jan; 158(1):8-10. PubMed ID: 8380219
    [No Abstract]   [Full Text] [Related]  

  • 49. The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina.
    Sullivan EA; Kamb ML; Jones JL; Meyer P; Philen RM; Falk H; Sinks T
    Arch Intern Med; 1996 May; 156(9):973-9. PubMed ID: 8624177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of Centers for Disease Control and Prevention criteria for the eosinophilia-myalgia syndrome in a geographically defined population.
    Spitzer WO; Haggerty JL; Berkson L; Davis W; Palmer W; Tamblyn R; Laprise R; Mulder LJ
    J Rheumatol Suppl; 1996 Oct; 46():73-9; discussion 79-80. PubMed ID: 8895183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eosinophilia-myalgia syndrome and peripheral eosinophilia.
    Schwartzberg M; Weber CA
    J Rheumatol; 1991 Dec; 18(12):1940-1. PubMed ID: 1795341
    [No Abstract]   [Full Text] [Related]  

  • 52. Eosinophilia-myalgia syndrome.
    Duffy J
    Mayo Clin Proc; 1992 Dec; 67(12):1201-2. PubMed ID: 1469933
    [No Abstract]   [Full Text] [Related]  

  • 53. Eosinophilia-myalgia syndrome: morbidity and mortality.
    Kaufman LD
    J Rheumatol; 1993 Oct; 20(10):1644-6. PubMed ID: 8295172
    [No Abstract]   [Full Text] [Related]  

  • 54. The eosinophilia-myalgia syndrome.
    Silver RM
    Clin Dermatol; 1994; 12(3):457-65. PubMed ID: 7954203
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.